AstraZeneca

AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site

WILMINGTON, DE — AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals …

AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site Read More
AscellaHealth

AscellaHealth Highlights Patient-First Approach to Rare Disease Therapy Distribution in New Podcast Series

BERWYN, PA — AscellaHealth, a global provider of tailored solutions for the specialty pharmaceutical industry, is emphasizing its patient-centric, flexible approach to distributing rare and complex disease therapies through a …

AscellaHealth Highlights Patient-First Approach to Rare Disease Therapy Distribution in New Podcast Series Read More

PurpleLab

PurpleLab and Comscore Bring Privacy-Compliant Healthcare Audiences to The Trade Desk

WAYNE, PA — PurpleLab® has announced a strategic partnership with Comscore to launch ID-free Predictive Audiences on The Trade Desk’s Contextual Marketplace. This initiative provides privacy-compliant targeting solutions for advertisers …

PurpleLab and Comscore Bring Privacy-Compliant Healthcare Audiences to The Trade Desk Read More

Food and Drug Administration

FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and significant changes in pharmaceutical labeling, marking advancements in treatment options …

FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings Read More